With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...
Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning.
Congress has approved a stopgap bill to fund the federal government through September 30 and avert a shutdown ahead of a ...
Republicans say their spending bill would let Trump defund whatever projects he wants. Chuck Schumer and Senate Dems are expected to help advance it.
(Reuters) - QXO is in discussions about a potential $11 billion deal for Beacon Roofing Supply, the companies said on Monday.